Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024362416> ?p ?o ?g. }
- W2024362416 endingPage "234" @default.
- W2024362416 startingPage "225" @default.
- W2024362416 abstract "Smoking cessation pharmacotherapy is a critical component of smoking cessation treatment, but most smokers use neither pharmacotherapy nor behavior counseling in attempts to quit smoking. The low rate of smoking cessation medication use is of great concern because it can negatively influence the odds of success in smoking cessation.This study was conducted to analyze how copayment may influence the likelihood of initiating smoking cessation pharmacotherapy following a reversed varenicline claim.A retrospective cohort analysis was performed using pharmacy claims data from a large national pharmacy benefits management company. Reversed claims were claims first approved by the health plan and then reversed by the pharmacy. The study population included patients with over-the-counter nicotine replacement therapy coverage and a reversed varenicline claim between January 2007 and April 2008 and who were naive to varenicline before the reversed claim. A multivariate logistic regression analysis was conducted to evaluate the probability of initiating any smoking cessation pharmacotherapy (varenicline, bupropion, and prescribed or over-the-counter nicotine replacement therapy) within 183 days of the reversed claim.A total of 20,451 patients met the inclusion criteria. The mean (SD) age of patients was 47.8 (12.4) years, with 57.41% being female. The majority (87.72%) were covered in commercial managed care plans. A total of 17,028 patients (83.26%) had at least 1 smoking cessation medication filled 6 months after their reversed claim. The odds ratios for patients who had any smoking cessation medication filled and copayments of $31 to $40, $41 to $60, or >$60 were 0.68, 0.48, and 0.35, respectively (all, P < 0.001), compared with patients with copayments of $0 to $5.The findings suggest that some patients might have been deterred by a high copayment (≥$31) and, ultimately, did not fill any smoking cessation treatments within 183 days of reversed varenicline claims. It is important to address this potential treatment gap to improve the effectiveness of smoking cessation therapy." @default.
- W2024362416 created "2016-06-24" @default.
- W2024362416 creator A5004596365 @default.
- W2024362416 creator A5004806314 @default.
- W2024362416 creator A5016395117 @default.
- W2024362416 creator A5040586236 @default.
- W2024362416 creator A5049632527 @default.
- W2024362416 creator A5086331068 @default.
- W2024362416 date "2011-02-01" @default.
- W2024362416 modified "2023-10-17" @default.
- W2024362416 title "Effects of Copayment on Initiation of Smoking Cessation Pharmacotherapy: An Analysis of Varenicline Reversed Claims" @default.
- W2024362416 cites W182001799 @default.
- W2024362416 cites W1963599036 @default.
- W2024362416 cites W1970485089 @default.
- W2024362416 cites W1973453264 @default.
- W2024362416 cites W1984959392 @default.
- W2024362416 cites W1996074019 @default.
- W2024362416 cites W2005263168 @default.
- W2024362416 cites W2024086064 @default.
- W2024362416 cites W2029896549 @default.
- W2024362416 cites W2036567678 @default.
- W2024362416 cites W2041879639 @default.
- W2024362416 cites W2053457282 @default.
- W2024362416 cites W2053780376 @default.
- W2024362416 cites W2061320251 @default.
- W2024362416 cites W2063004281 @default.
- W2024362416 cites W2074736712 @default.
- W2024362416 cites W2090024638 @default.
- W2024362416 cites W2100536330 @default.
- W2024362416 cites W2107131300 @default.
- W2024362416 cites W2107200746 @default.
- W2024362416 cites W2124448307 @default.
- W2024362416 cites W2125607515 @default.
- W2024362416 cites W2155441883 @default.
- W2024362416 cites W2162125478 @default.
- W2024362416 cites W2164386461 @default.
- W2024362416 doi "https://doi.org/10.1016/j.clinthera.2011.02.013" @default.
- W2024362416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21497706" @default.
- W2024362416 hasPublicationYear "2011" @default.
- W2024362416 type Work @default.
- W2024362416 sameAs 2024362416 @default.
- W2024362416 citedByCount "18" @default.
- W2024362416 countsByYear W20243624162012 @default.
- W2024362416 countsByYear W20243624162013 @default.
- W2024362416 countsByYear W20243624162014 @default.
- W2024362416 countsByYear W20243624162015 @default.
- W2024362416 countsByYear W20243624162016 @default.
- W2024362416 countsByYear W20243624162017 @default.
- W2024362416 countsByYear W20243624162020 @default.
- W2024362416 countsByYear W20243624162021 @default.
- W2024362416 countsByYear W20243624162022 @default.
- W2024362416 countsByYear W20243624162023 @default.
- W2024362416 crossrefType "journal-article" @default.
- W2024362416 hasAuthorship W2024362416A5004596365 @default.
- W2024362416 hasAuthorship W2024362416A5004806314 @default.
- W2024362416 hasAuthorship W2024362416A5016395117 @default.
- W2024362416 hasAuthorship W2024362416A5040586236 @default.
- W2024362416 hasAuthorship W2024362416A5049632527 @default.
- W2024362416 hasAuthorship W2024362416A5086331068 @default.
- W2024362416 hasConcept C104863432 @default.
- W2024362416 hasConcept C126322002 @default.
- W2024362416 hasConcept C142724271 @default.
- W2024362416 hasConcept C143095724 @default.
- W2024362416 hasConcept C151956035 @default.
- W2024362416 hasConcept C156957248 @default.
- W2024362416 hasConcept C160735492 @default.
- W2024362416 hasConcept C162324750 @default.
- W2024362416 hasConcept C167135981 @default.
- W2024362416 hasConcept C194828623 @default.
- W2024362416 hasConcept C2777053506 @default.
- W2024362416 hasConcept C2777843972 @default.
- W2024362416 hasConcept C2779848557 @default.
- W2024362416 hasConcept C2779908668 @default.
- W2024362416 hasConcept C2780478649 @default.
- W2024362416 hasConcept C2908647359 @default.
- W2024362416 hasConcept C2983635472 @default.
- W2024362416 hasConcept C500440147 @default.
- W2024362416 hasConcept C50522688 @default.
- W2024362416 hasConcept C512399662 @default.
- W2024362416 hasConcept C71924100 @default.
- W2024362416 hasConcept C99454951 @default.
- W2024362416 hasConceptScore W2024362416C104863432 @default.
- W2024362416 hasConceptScore W2024362416C126322002 @default.
- W2024362416 hasConceptScore W2024362416C142724271 @default.
- W2024362416 hasConceptScore W2024362416C143095724 @default.
- W2024362416 hasConceptScore W2024362416C151956035 @default.
- W2024362416 hasConceptScore W2024362416C156957248 @default.
- W2024362416 hasConceptScore W2024362416C160735492 @default.
- W2024362416 hasConceptScore W2024362416C162324750 @default.
- W2024362416 hasConceptScore W2024362416C167135981 @default.
- W2024362416 hasConceptScore W2024362416C194828623 @default.
- W2024362416 hasConceptScore W2024362416C2777053506 @default.
- W2024362416 hasConceptScore W2024362416C2777843972 @default.
- W2024362416 hasConceptScore W2024362416C2779848557 @default.
- W2024362416 hasConceptScore W2024362416C2779908668 @default.
- W2024362416 hasConceptScore W2024362416C2780478649 @default.
- W2024362416 hasConceptScore W2024362416C2908647359 @default.
- W2024362416 hasConceptScore W2024362416C2983635472 @default.